FAM19A5 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 9.230200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
5.413000E-01
Normal-vs-Stage2
9.436000E-01
Normal-vs-Stage3
6.867800E-01
Normal-vs-Stage4
6.380000E-01
Stage1-vs-Stage2
1.172810E-01
Stage1-vs-Stage3
5.804200E-01
Stage1-vs-Stage4
2.323200E-01
Stage2-vs-Stage3
4.611400E-01
Stage2-vs-Stage4
1.875430E-01
Stage3-vs-Stage4
3.316600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
9.251800E-01
Normal-vs-AfricanAmerican
9.202200E-01
Normal-vs-Asian
9.515600E-01
Caucasian-vs-AfricanAmerican
9.729600E-01
Caucasian-vs-Asian
8.594800E-01
AfricanAmerican-vs-Asian
9.456400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
9.792400E-01
Normal-vs-Female
8.680200E-01
Male-vs-Female
3.850200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.544800E-01
Normal-vs-Age(41-60Yrs)
7.381600E-01
Normal-vs-Age(61-80Yrs)
9.166200E-01
Normal-vs-Age(81-100Yrs)
5.699200E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
1.402650E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.142600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.791800E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
9.263200E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.302200E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.419360E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
7.981200E-01
Normal-vs-Daily Drinker
7.958400E-01
Normal-vs-Weekly Drinker
7.793600E-01
Normal-vs-Occasional Drinker
7.531200E-01
Normal-vs-Social Drinker
8.050400E-01
Non Drinker-vs-Daily Drinker
9.968000E-01
Non Drinker-vs-Weekly Drinker
2.592800E-01
Non Drinker-vs-Occasional Drinker
3.767000E-01
Non Drinker-vs-Social Drinker
2.966200E-01
Daily Drinker-vs-Weekly Drinker
3.426600E-01
Daily Drinker-vs-Occasional Drinker
3.770800E-01
Daily Drinker-vs-Social Drinker
3.016400E-01
Weekly Drinker-vs-Occasional Drinker
5.653200E-01
Weekly Drinker-vs-Social Drinker
7.921800E-01
Occasional Drinker-vs-Social Drinker
5.018200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.067590E-02
Normal-vs-Grade 2
<1E-12
Normal-vs-Grade 3
1.62581059726108E-12
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
4.860400E-01
Grade 1-vs-Grade 3
3.402600E-01
Grade 1-vs-Grade 4
1.067590E-02
Grade 2-vs-Grade 3
1.893760E-01
Grade 2-vs-Grade 4
<1E-12
Grade 3-vs-Grade 4
1.62581059726108E-12
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
8.736400E-01
Normal-vs-NonDiabetic
8.598200E-01
Diabetic-vs-NonDiabetic
2.161600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
7.950800E-01
Normal-vs-NoPancreatitis
9.019000E-01
Pancreatitis-vs-NoPancreatitis
9.794800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
8.025800E-01
Normal-vs-N1
9.686800E-01
N0-vs-N1
2.951800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.032600E-01
Normal-vs-TP53-NonMutant
9.315600E-01
TP53-Mutant-vs-TP53-NonMutant
2.508600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
